Previous 10 | Next 10 |
Signaling its determination to close the deal amid rival offers, AcelRx Pharmaceuticals ( ACRX -4.0% ) has increased its bid for Tetraphase Pharmaceuticals ( TTPH -8.3% ) to $30M in cash and stock plus an additional $14.5M in cash payable under a contingent value right (CVR). More news...
La Jolla Pharmaceutical (NASDAQ: LJPC ) -24% . More news on: La Jolla Pharmaceutical Company, Arcus Biosciences, Inc., Mitcham Industries, Inc., Stocks on the move, , Read more ...
Tetraphase Pharmaceuticals (NASDAQ: TTPH ) discloses that it received an unsolicited bid yesterday from Melinta Therapeutics (NASDAQ: MLNT ) for $27.0M in cash plus an additional $12.5M payable under a contingent value right (CVR). More news on: Tetraphase Pharmaceuticals, Inc., Melinta ...
La Jolla Pharmaceuticals (LJPC) is undergoing a critical transition at this point in time as it seemingly kills off R&D to focus on commercialization. At the same time, overall levels of transparency are on the lower end of the spectrum, which puts LJPC in a highly speculative position. ...
Introduction Shares in battered biotech Tetraphase Pharmaceuticals ( TTPH ) were yesterday’s big winner in US trading, moving up 78% after La Jolla ( LJPC ) announced it had submitted a 22M non-binding all-cash proposal to acquire the company, plus an additional 12.5M in Contingen...
TetraPhase Pharmaceuticals (NASDAQ: TTPH ) discloses that it has received an unsolicited bid from La Jolla Pharmaceutical Company (NASDAQ: LJPC ) consisting of $22M in cash and an additional $12.5M payable via a contingent value right (CVR). The board is considering the offer. More news ...
La Jolla Pharmaceutical (NASDAQ: LJPC ): Q1 GAAP EPS of -$0.32 beats by $0.41 . More news on: La Jolla Pharmaceutical Company, Earnings news and commentary, Healthcare stocks news, , Read more ...
SAN DIEGO, May 04, 2020 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases, today announced financial results f...
ANI Pharmaceuticals Submit Application for Relaunching Cortrophin Gel ANI Pharmaceuticals Inc. ( ANIP ) announced that it has submitted a Prior Approval Supplement to the FDA. The supplement has been filed with the Endocrinology Division of the regulatory body. The application pertains to ...
SAN DIEGO, April 13, 2020 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases, today announced that it is provid...
News, Short Squeeze, Breakout and More Instantly...
La Jolla Pharmaceutical Company Company Name:
LJPC Stock Symbol:
NASDAQ Market:
La Jolla Pharmaceutical Company Website:
Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified holding company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of L...
The biotech investment sector has always been its own market, very distinct from other sectors. So it was no surprise that when most sectors turned slowly upward after the pandemic-inspired crash, Biotech (XBI) rose 164%, exceeding the overall market (SPY) performance by triple digits. Then, a...